Literature DB >> 9692346

Influence of 5-lipoxygenase on in vitro growth of human mammary carcinoma cell line MCF-7.

A Przylipiak1, J Hafner, J Przylipiak, F M Köhn, B Runnebaum, T Rabe.   

Abstract

The aim of this study was to investigate the direct effect of 5-lipoxygenase (5-LO) on the growth of human mammary cancer cells MCF-7 in vitro. Cell growth was measured according to the level of 3H-thymidine incorporation. 5-LO was shown to inhibit 3H-thymidine incorporation. The inhibitory effect was 19, 42 and 78% when administered at concentrations of 0.1, 0.2 or 0.5 U/ml, respectively. Its effect was time- and dose-dependent and was statistically significant at concentrations of 0.2 and 0.5 U/ml. We have also shown that the specific 5-LO inhibitor MK-886 (1 microM) lifts the inhibitory effect of 5-LO (0.2 U/ml). Moreover, when treated with an activator of 5-lipoxygenase calcium ionophore A23187 (10 microM) MCF-7 cells synthesize LTB4. The results of this study are evidence of the role of 5-lipoxygenase in the regulation of human mammary cancer cells growth in vitro.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9692346     DOI: 10.1159/000010000

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


  3 in total

1.  Enzymes involved in the biosynthesis of leukotriene B4 and prostaglandin E2 are active in sebaceous glands.

Authors:  Theodosios Alestas; Ruta Ganceviciene; Sabine Fimmel; Karin Müller-Decker; Christos C Zouboulis
Journal:  J Mol Med (Berl)       Date:  2005-12-31       Impact factor: 4.599

Review 2.  Anti-Inflammatory Drugs as Anticancer Agents.

Authors:  Silvia Zappavigna; Alessia Maria Cossu; Anna Grimaldi; Marco Bocchetti; Giuseppe Andrea Ferraro; Giovanni Francesco Nicoletti; Rosanna Filosa; Michele Caraglia
Journal:  Int J Mol Sci       Date:  2020-04-09       Impact factor: 5.923

3.  ALOX5-5-HETE promotes gastric cancer growth and alleviates chemotherapy toxicity via MEK/ERK activation.

Authors:  Jianjun Tang; Chuang Zhang; Jingjing Lin; Peng Duan; Jian Long; Hongyan Zhu
Journal:  Cancer Med       Date:  2021-06-13       Impact factor: 4.452

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.